Solara Active Pharma Sciences informs about transcript of conference call

21 Feb 2024 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Solara Active Pharma Sciences has informed that it enclosed the transcript of the earnings conference call for the quarter ended December 31, 2023, conducted after the meeting of Board of Directors held on February 14, 2024. The above information is also available on the website of Company at https://solara.co.in/investorrelations/investor-update.

The above information is a part of company’s filings submitted to BSE.

Solara Active Pharma Share Price

686.95 -33.60 (-4.66%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.